Delivery Order SPE2DB22D9353-SPE2DB24FX2AA
Award Date
7/2/24
Potential Completion Date
7/3/24
Potential Value
$34K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $7,330.50, is for the delivery of Fasenra 30 mg/mL syringes. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price...
The U.S. Defense Logistics Agency (DLA) awarded a $2,443.50 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the drug Fasenra Pen 30 mg/mL. This delivery order was issued under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. Through this IDC vehicle, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical items...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order worth $7,330.50 under a broader indefinite delivery contract (IDV) with the Defense Logistics Agency (DLA) valued up to $4,999,999 through 2025. The order is for the pharmaceutical product FASENRA 30 MG/ML SYRINGE. The IDV, contract 4600082013 under the DLA's SPE2DB program, enables the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to fulfill...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,330.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of Fasenra 30 mg/ml syringes, and is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999 that runs through December 31, 2025. This IDC, under the SPE2DB program, allows the DLA to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $24,435.00, is for the delivery of Fasenra 30 mg/ml syringes and does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 30 mg/mL syringes of Fasenra, a pharmaceutical product. The contract has a potential value of $39,096.00 and a completion date of January 2, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $39,096.00 firm fixed-price delivery order is for the supply of Fasenra 30 mg/ml syringes. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC enables the DLA to issue delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $7,330.50 contract is for the supply of Fasenra 30 mg/ml syringes, a biologic medication used to treat severe asthma. The award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
The U.S. Defense Logistics Agency (DLA) awarded a $4,887.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of FASENRA 30 MG/ML SYRINGEML, a specialized pharmaceutical product, with a period of performance through November 8, 2024. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,443.50 firm fixed-price delivery order is for the supply of FASENRA 30 MG/ML SYRINGEML and has a completion date of July 17, 2024. This award is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at up to...